147 related articles for article (PubMed ID: 35212312)
1. Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.
Lv L; Yuan X; Jiang L
Medicine (Baltimore); 2022 Feb; 101(8):e28994. PubMed ID: 35212312
[TBL] [Abstract][Full Text] [Related]
2. Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention: A protocol for a systematic review and network meta-analysis.
Zhu Z; Wang Y; Liao W; Li H; Wang D
Medicine (Baltimore); 2018 Jun; 97(24):e11062. PubMed ID: 29901609
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Aspirin With Combined Compound Danshen Dropping Pills on Hemorheology and Blood Lipids in Middle-Aged and Elderly Patients With CHD: A Systematic Review and Meta-Analysis.
Liu Z; Li G; Ma Y; Lin L
Front Public Health; 2021; 9():664841. PubMed ID: 34222174
[No Abstract] [Full Text] [Related]
4. [Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention].
Dai QQ; Shi ZF; Hu JY; Han SJ; Zhong CM; Guan MK; Tian GH; Shang HC
Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1498-1510. PubMed ID: 33787149
[TBL] [Abstract][Full Text] [Related]
5. Compound Danshen dripping pills in treating with coronary heart disease: A protocol for systematic review and meta-analysis.
Sun L; Zhang YN
Medicine (Baltimore); 2022 Feb; 101(7):e28927. PubMed ID: 35363219
[TBL] [Abstract][Full Text] [Related]
6. Guanxin Danshen Dripping Pills Improve Quality of Life and Cardiovascular Prognoses of CHD Patients after PCI with Anxiety or Depression (GLAD Study): A Randomized Double-Blind Placebo-Controlled Study.
Wang CL; Huan N; Wang PL; Geng QS; Ma WL; Ma LH; Jiang HY; Meng XP; Zhang DW; Gou XJ; Hu DY; Chen KJ
Chin J Integr Med; 2023 Mar; 29(3):195-204. PubMed ID: 36301456
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of Xinkeshu on coronary artery disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Chen M; Zhong G; Men L; Liu Q; Luan J
Medicine (Baltimore); 2021 Nov; 100(46):e27912. PubMed ID: 34797346
[TBL] [Abstract][Full Text] [Related]
8. Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Zhu K; Zheng YS; Fang Y
Medicine (Baltimore); 2020 Oct; 99(44):e22918. PubMed ID: 33126352
[TBL] [Abstract][Full Text] [Related]
9. The effect of Huoxue Huayu decoction on restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.
Hou Y; Li X; Wang X; Dong T; Yang J
Medicine (Baltimore); 2022 Jan; 101(4):e28677. PubMed ID: 35089215
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of acupuncture combined with Xuefu Zhuyu Decoction on major adverse cardiovascular events after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Ma Q; Cai Z; Sui L; Wang X
Medicine (Baltimore); 2022 Nov; 101(46):e31735. PubMed ID: 36401381
[TBL] [Abstract][Full Text] [Related]
11. [Systematic evaluation on efficacy and safety of Gingko Ketone Ester Dropping Pills in treatment of angina pectoris and coronary heart disease].
Wang KY; Wang HC; Jin XY; Zhang MY; Li N; Pang WT; Wang H; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2317-2324. PubMed ID: 34047136
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of auricular acupuncture in patients with depression after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Lu R; Shi R; Zhang M; Shao X; Xue W; Guo Q; Wang C; Deng Y
Medicine (Baltimore); 2022 Apr; 101(15):e29173. PubMed ID: 35475802
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Compound Danshen Dripping Pills combined with western medicine in the treatment of diabetic retinopathy: a systematic review and meta-analysis of randomized controlled trials.
Huang H; Li Y; Huang Q; Lei R; Zou W; Zheng Y
Ann Palliat Med; 2021 Oct; 10(10):10954-10962. PubMed ID: 34763458
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Danhong injection on endothelial function and inflammatory factors after the percutaneous coronary intervention for coronary heart disease: A protocol of systematic review and meta-analysis of randomized controlled trials.
Li S; Duan S; Ning Y; Zhang H; Zheng Q
Medicine (Baltimore); 2020 Jul; 99(27):e20783. PubMed ID: 32629660
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): A nationwide Cohort Study.
Bai R; Yang Q; Xi R; Che Q; Zhao Y; Guo M; Dong G; Gao Z; Fu C; Wang P; Gu F; Du J; Zhang D; Duan W; Li L; Shi D
Phytomedicine; 2023 Jan; 109():154554. PubMed ID: 36610159
[TBL] [Abstract][Full Text] [Related]
16. Effects of PCSK9 inhibitors on coronary microcirculation, inflammation and cardiac function in patients with CHD after PCI: a protocol for systematic review and meta-analysis.
Ye X; Wang S; Liu X; Wu Q; Lv Y; Lv Q; Li J; Li L; Yang Y
BMJ Open; 2023 Sep; 13(9):e074067. PubMed ID: 37723117
[TBL] [Abstract][Full Text] [Related]
17. Clinical study of guanxin danshen dropping pills combined with meglumine cyclophosphate in the treatment of angina pectoris in elderly patients with coronary heart disease.
Yu C; Zhang Y; Liu X
Panminerva Med; 2023 Dec; 65(4):549-551. PubMed ID: 34544224
[No Abstract] [Full Text] [Related]
18. Recommendations on the Clinical Use of Compound Danshen Dripping Pills.
Writing Group of Recommendations of Expert Panel from Chinese Geriatrics Society on the Clinical Use of Compound Danshen Dripping Pills
Chin Med J (Engl); 2017 Apr; 130(8):972-978. PubMed ID: 28397728
[No Abstract] [Full Text] [Related]
19. Chinese Herbal Medicines for Restenosis After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
Wu J; Zhao L; Lin K; Lu L; Luo C
J Altern Complement Med; 2019 Oct; 25(10):983-992. PubMed ID: 31464515
[No Abstract] [Full Text] [Related]
20. Compound Danshen (Salvia miltiorrhiza) dripping pill for coronary heart disease: an overview of systematic reviews.
Luo J; Song W; Yang G; Xu H; Chen K
Am J Chin Med; 2015; 43(1):25-43. PubMed ID: 25582415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
